Did you mean
virus vector

Search results - 64 results

Complete genome reconstruction of the global and European regional dispersal history of the lumpy skin disease virus.

Abstract: Lumpy skin disease virus (LSDV) causes a disease of economic importance affecting cattle. Its global epidemiology is complex due to the combination of vector-borne and anthropogenic spread, the ...

Complete genome reconstruction of the global and European regional dispersal history of the lumpy skin disease virus.

Abstract: Lumpy skin disease virus (LSDV) causes a disease of economic importance affecting cattle. Its global epidemiology is complex due to the combination of vector-borne and anthropogenic spread, the ...

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.

replication-defective viral vectors commonly used in gene therapy or vaccination. To our knowledge, this article presents the most extensive and up-to-date review of shedding data reported with OV employed in clinics. ...

Belgian Mosquitoes Are Competent for Japanese Encephalitis Virus and Readily Feed on Pigs, Suggesting a High Vectorial Capacity.

vector-overgedragen ziekten Viral reemerging enzootic and bee diseases’ Virale heropduikende, enzoötische en bijen-ziekten Maladies virales réémergentes, enzootiques et des abeilles Manuscript versions:  DOI:  ...

Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium

confirmed by whole genome sequencing and vaccinated with a homologous (mRNA for prime/mRNA for boost) or heterologous (viral vector for prime/mRNA for boost) prime-boost vaccination schedule were included in ...

Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium

investigated effectiveness of (1) mRNA booster vaccination versus primary vaccination only and (2) heterologous (viral vector-mRNA) versus homologous (mRNA-mRNA) prime-boost vaccination against severe outcomes ...

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

the reported antibody response to the licensed adenoviral vector vaccines. These data suggest that reduced doses of the BNT162 b2 mRNA vaccine may offer additional benefit as compared to the vaccines ...

Identification of diffusion routes of O/EA-3 topotype of foot-and-mouth disease virus in Africa and Western Asia between 1974 and 2019- a phylogeographic analysis.

evolutionary phylodynamics of the causative serotype O viral strains all belonging to the East-Africa 3 topotype (O/ EA-3). We analyzed a total of 489 sequences encoding the FMDV VP1 genome region generated from ...

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.

compared to viral vector vaccines: 66% and 80% for Ad26COV2.S and ChAdOx1 respectively (Alpha, 0-50 days after vaccination). Delta was associated with a 40% increase in odds of transmission and a decrease of ...

QR code

QR code for this page URL